All Notifications
( articles )
Thyrocare Technologies has expanded its presence in Northern India by acquiring the pathology bus...
( Comment )
Veeda, providing a broad range of services across most aspects of the drug development & drug launch throughout global markets has raised capital from Sixth Sense Ventures & others.
Founded in 2004, Veeda has grown from a single facility in 2004 to now having 4 facilities with a capability to process 1 lakh+ samples monthly. Veeda provides services across drug value chain incl BA/BE studies, full suits of Clinical trials, pharmacokinetics studies & trials in generic molecules, NCEs, large molecules & Biosimilars.
Till date, Veeda has conducted over 3,500 trials, developed 1,000+ bio-analytical methods spread across generics, NCEs & Biosimilars & completed 85 successful regulatory audits with UK-MHRA, ANVISA & DCGI. The capital raised will be used towards Veeda’s objective of backward as well as forward integration by evaluating inorganic growth opportunities.
( articles )
Starting soon, Cochin International Airport (CIAL) will introduce a new self-immigration process...
( Financial update )
Financials of Hindusthan Engineering & Industries Limited Unlisted Shares are updated for 2023
( Financial update )
Financials of Electrosteel Steels Limited Unlisted Shares are updated for 2024
( Financial update )
Financials of Hindusthan Engineering & Industries Limited Unlisted Shares are updated for 2022
( Financial update )
Financials of Royalcare Super Speciality Hospitals are updated for 2023
( Financial update )
Financials of Royalcare Super Speciality Hospitals are updated for 2022
( Financial update )
Financials of Royalcare Super Speciality Hospitals are updated for 2021
approval of the resolution plan submitted by IndusInd International Holdings Ltd
